# Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway

**Authors:** Peng Xu, Handong Wang, Hao Pan, Jiakai Chen, Chulei Deng

PMC · DOI: 10.1007/s00280-026-04874-0 · Cancer Chemotherapy and Pharmacology · 2026-03-16

## Full-text entities

- **Genes:** STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}
- **Diseases:** Cancer (MESH:D009369), glioblastoma (MESH:D005909)
- **Chemicals:** A172 (-), Anlotinib (MESH:C000625192), temozolomide (MESH:D000077204)
- **Cell lines:** U251 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0021), U87 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12992338/full.md

---
Source: https://tomesphere.com/paper/PMC12992338